U.S. TECH

U.S. Biotech News

U.S. biotechnology coverage addresses clinical research, regulatory pathways, funding and the national industry shaping how biological discoveries become products. Reporting here follows what advances and what stops it.

Science Corporation Raises $400M at $3.5B Value

Science Corporation Raises $400M at $3.5B Value

The brain-chip company's PRIMA device is approved in Europe and is now pursuing a U.S. route through the FDA.

Live Poll

Would you trust a brain implant to treat a serious medical condition?


Recent news


More in Biotech

The beat runs across clinical trial results and their regulatory submissions, gene therapy and CRISPR program development, genomics platform adoption, biotech funding and acquisition, and the agency review processes that determine what reaches patients. It explains what a trial result demonstrates and what a regulatory decision requires next. Approval timelines shape the sector's commercial structure more than any single scientific finding because they determine when a therapy becomes a marketable product. Acquisition activity receives sustained attention since it regularly determines which research programs survive and which are discontinued.